Editas Medicine (EDIT) Revenue (2015 - 2026)
Editas Medicine's Revenue was $7.54 million in Q3 2025, compared with $61,000 a year earlier and up 110.8% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Revenue (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Editas Medicine's Revenue was $46.38 million through Sep 30, 2025, down 24.9% year-over-year; for FY2024, it was $32.31 million, down 58.6% from FY2023.
- Revenue shows a five-year compound annual growth rate of 9.5% (FY2019 to FY2024).
- In earlier years, Revenue was $78.12 million in FY2023 (+296.3%), $19.71 million in FY2022 (-22.8%), $25.54 million in FY2021 (-71.8%) and $90.73 million in FY2020 (+341.9%).
- Quarterly Revenue has moved between $42,000 (Q3 2022) and $60.05 million (Q4 2023) over five years.
- Compared with a year earlier, Revenue was higher in three of the last seven quarters, with growth averaging 201.1%.
- The best year-over-year quarter for Revenue over five years was Q4 2023 (growth of 818.7%); the worst was Q3 2022 (a decline of 99.3%).
- Per Business Quant data, EDIT's Revenue in the three quarters before Q3 2025 was $3.58 million (Q2 2025), $4.66 million (Q1 2025) and $30.6 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Editas Medicine | 385.55 Mn | -286.59 Mn | 8.20 Mn | 10.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.37 Mn |
| Jun 30, 2026 | 11.89 Mn |
| Mar 31, 2026 | 2.83 Mn |
| Dec 31, 2025 | 24.74 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 30.60 Mn |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 513,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 60.05 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 2.89 Mn |
| Mar 31, 2023 | 9.85 Mn |
| Dec 31, 2022 | 6.54 Mn |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 6.36 Mn |
| Mar 31, 2022 | 6.77 Mn |
| Dec 31, 2021 | 12.47 Mn |
API Access
Editas Medicine Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();